hMAO-B/MB-COMT-IN-1

Overview

hMAO-B/MB-COMT-IN-1 is a dual MAO-B/MB-COMT inhibitor ( IC 50 s: 2.5 μΜ for hMAO-B, 3.84 μΜ for MB-COMT). hMAO-B/MB-COMT-IN-1 protects cells against oxidative damage. hMAO-B/MB-COMT-IN-1 can be used in the research of neurodegeneration disease, such as Parkinson’s Disease (PD).

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Depression | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > COMT

Product Information

• Catalog No.: HY-151388
• CAS No.: 254974-70-4
• Molecular Formula: C16H19NO3
• Molecular Weight: 273.33
• Purity: 98.04%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (9.15 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source